98%
921
2 minutes
20
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10557-025-07761-7 | DOI Listing |
Cardiovasc Drugs Ther
August 2025
School of Nursing, Shanxi Medical University, Taiyuan, 030000, China.
JAMA Cardiol
August 2025
British Heart Foundation Centre of Research Excellence, University of Edinburgh, Edinburgh, United Kingdom.
Importance: Healthy lifestyles and uptake of primary preventive therapies for cardiovascular disease remain poor.
Objective: To determine the impact of coronary computed tomography (CT) angiography on healthy lifestyle behaviors, acceptance of recommended treatments, and modification of risk factors as compared with guideline-directed cardiovascular risk scoring.
Design, Setting, And Participants: This was a nested substudy conducted from September 2020 to August 2024 of a randomized clinical trial where participants underwent cardiovascular risk scoring or coronary CT angiography.
J Clin Endocrinol Metab
February 2025
Laboratory of Exercise Physiology, Faculty of Physical Education, University of Campinas, 13083-851 São Paulo, Brazil.
J Clin Endocrinol Metab
February 2025
Clinical Science Institute, University Hospital Galway, Newcastle Road, Galway, H91 YR71, Ireland.
JAMA Oncol
September 2024
Institute for Precision Health, University of California, Los Angeles.
Importance: Observational data have shown that postdiagnosis exercise is associated with reduced risk of prostate cancer death. The feasibility and tumor biological activity of exercise therapy is not known.
Objective: To identify recommended phase 2 dose of exercise therapy for patients with prostate cancer.